Thorax and Chest Cancer Clinical Trials

The most recent listing of current clinical trials for thorax and chest cancers — including lung, esophagus and thymoma — appears below.  

Site: Thorax/Chest (Includes Lung, Esophagus and Thymoma)

Protocol ID    Title

CALGB-30610/RTO- 0538    Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

ECOG-1512    A Randomized Phase II Trial of Erlotinib, Cabozantinib, or Erlotinib plus Cabozantinib as 2nd or 3rd Line Therapy in Patients with EGFR Wild-Type NSCLC

NOVARTIS-CLDK378A2303    A Phase III, Multicenter, Randomized, Open-Label Study Of Oral LDK378 Versus Standard Chemotherapy In Adult Patients With ALK-Rearranged (ALK-Positive) Advanced Non-Small Cell Lung Cancer Who Have Been Treated Previously With Chemotherapy (Platinum Doublet) And Crizotinib

RTOG-0839    Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer

RTOG-0937    Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

RTOG-1010    A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

RTOG-1106/ACRIN-6697    Randomized Phase II Trial Of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT And Modern Technology In Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

RTOG-1175/CALGB-80803    Randomized Phase II Trial Of PET Scan-Directed Combined Modality Therapy In Esophageal Cancer